Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

497
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
497
Overview of Exosomes01:36

Overview of Exosomes

2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

387
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
387
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

3.4K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Henagliflozin attenuates adverse ventricular remodeling and improves cardiometabolic parameters in patients with type 2 diabetes and hypertension: real-world evidence from a propensity score-matched analysis.

Cardiovascular diabetology·2026
Same author

Mid-to-long-term follow-up study on the application of cystic duct patency test and cystic duct exploration in laparoscopic cholecystectomy for calculous cholecystitis: Xinjiang-Gu laparoscopic cystic duct exploration.

Surgical endoscopy·2026
Same author

An Integrated muti-omics cell atlas of the human trabecular meshwork and ciliary body.

bioRxiv : the preprint server for biology·2026
Same author

Macropinocytosis: A central orchestrator in tumor development and therapeutic resistance.

Biochimica et biophysica acta. Reviews on cancer·2026
Same author

A Primary Open-Angle Glaucoma Locus Near Transcription Factor <i>PRRX1</i> Identified in the Million Veteran Program.

Ophthalmology science·2026
Same author

Therapeutically Engineering Exosomes to Target CD206+ M2 Macrophages to Prevent the Development of Primary Tumors and Distal Metastases in Breast Cancers.

Cancers·2026

Related Experiment Video

Updated: May 29, 2025

Characterizing Extracellular Vesicles from Biological Fluids
05:07

Characterizing Extracellular Vesicles from Biological Fluids

Published on: February 28, 2025

215

Extracellular Vesicles and Glaucoma: Opportunities and Challenges.

Mofazzal Hossain1, Yutao Liu1,2,3

  • 1Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia, USA.

Current Eye Research
|February 3, 2025
PubMed
Summary

Extracellular vesicles (EVs) play a key role in glaucoma pathogenesis and show promise as biomarkers and therapeutics. Further research into EV signaling pathways is crucial for early detection and effective glaucoma treatment.

Keywords:
Exosomeextracellular vesiclesglaucomamiRNA

More Related Videos

Direct Stochastic Optical Reconstruction Microscopy of Extracellular Vesicles in Three Dimensions
09:36

Direct Stochastic Optical Reconstruction Microscopy of Extracellular Vesicles in Three Dimensions

Published on: August 26, 2021

3.7K
Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

6.3K

Related Experiment Videos

Last Updated: May 29, 2025

Characterizing Extracellular Vesicles from Biological Fluids
05:07

Characterizing Extracellular Vesicles from Biological Fluids

Published on: February 28, 2025

215
Direct Stochastic Optical Reconstruction Microscopy of Extracellular Vesicles in Three Dimensions
09:36

Direct Stochastic Optical Reconstruction Microscopy of Extracellular Vesicles in Three Dimensions

Published on: August 26, 2021

3.7K
Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

6.3K

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Biochemistry

Background:

  • Glaucoma is a leading cause of irreversible blindness due to progressive visual field loss.
  • Exact pathological mechanisms of glaucoma remain elusive, necessitating research into early detection and therapeutic strategies.
  • Extracellular vesicles (EVs), including exosomes, are increasingly recognized for their role in cell-cell communication and disease processes.

Purpose of the Study:

  • To comprehensively review the multifaceted role of extracellular vesicles (EVs) in glaucoma.
  • To explore EVs as potential causative factors, biomarkers, and therapeutic agents in glaucoma.
  • To identify challenges and future directions in utilizing EVs for glaucoma management.

Main Methods:

  • Conducted a literature search across PubMed, Google Scholar, and Web of Science.
  • Reviewed studies investigating the role of EVs in glaucoma pathogenesis, biomarker discovery, and therapeutic potential.
  • Focused on literature detailing EV content alterations and their involvement in disease pathways.

Main Results:

  • Differential expression of EV miRNA and proteins is altered in glaucoma, impacting aqueous humor drainage tissues.
  • EV contents contribute to glaucoma through pathways like extracellular matrix remodeling and oxidative stress transmission.
  • Mesenchymal stem cell-derived EVs show potential for protecting the optic nerve and treating glaucoma.

Conclusions:

  • Extracellular vesicles are integral to glaucoma, influencing pathogenesis and offering therapeutic avenues.
  • Significant challenges remain in identifying key EV signaling molecules driving glaucoma etiology.
  • Future research should focus on harnessing EVs for improved glaucoma diagnosis and treatment strategies.